Scope
Reference
C366698
Description
NHS National Framework for Golimumab Injection commencing 1st November 2025
Offer reference number: CM/TNS/25/5724
Period of framework: 1 November 2025 to 31 October 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Commercial tool
Establishes a framework
Contract 1. NHS National Framework for Golimumab Injection commencing 1st November 2025
Suppliers (3)
Contract value
- £60,000,000 excluding VAT
- £72,000,000 including VAT
Above the relevant threshold
Award decision date
26 August 2025
Date assessment summaries were sent to tenderers
1 September 2025
Standstill period
- End: 10 September 2025
- 8 working days
Earliest date the contract will be signed
22 September 2025
Contract dates (estimated)
- 1 November 2025 to 31 October 2026
- Possible extension to 31 October 2029
- 4 years
Description of possible extension:
option or options to extend (at the discretion of the Authority) up to maximum of 24 months.
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Information about tenders
- 3 tenders received
- 3 tenders assessed in the final stage:
- 1 submitted by small and medium-sized enterprises (SME)
- 0 submitted by voluntary, community and social enterprises (VCSE)
- 3 suppliers awarded contracts
- 0 suppliers unsuccessful (details included for contracts over £5 million)
Procedure
Procedure type
Open procedure
Suppliers
Janssen Cilag Ltd
- Companies House: 01027904
50-100 Holmers Farm Way
High Wycombe
HP12 4EG
United Kingdom
Email: commercialjc@its.jnj.com
Region: UKJ13 - Buckinghamshire CC
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Associated people/organisations:
None
Contract 1. NHS National Framework for Golimumab Injection commencing 1st November 2025
MERCURY PHARMACEUTICALS LIMITED
- Companies House: 02619880
Dashwood House
London
EC2M 1QS
United Kingdom
Region: UKI31 - Camden and City of London
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Associated people/organisations:
None
Contract 1. NHS National Framework for Golimumab Injection commencing 1st November 2025
ORIFARM UK LTD
- Companies House: 10015046
Ground Floor, Suite A2 Breakspear Way
Hemel Hempstead
HP2 4TZ
United Kingdom
Email: uk_enquiries@orifarm.com
Region: UKH23 - Hertfordshire
Small or medium-sized enterprise (SME): Yes
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Associated people/organisations:
None
Contract 1. NHS National Framework for Golimumab Injection commencing 1st November 2025
Contracting authority
NHS England
- Public Procurement Organisation Number: PDPT-3135-BWWY
Wellington House, 133-135 Waterloo Rd
London
SE1 8UG
United Kingdom
Email: katie.noonan@nhs.net
Website: https://www.england.nhs.uk/
Region: UKI45 - Lambeth
Organisation type: Public authority - central government